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Abstract
Background: Overweight in Guadeloupe is a public health matter affecting children and adults. In the present
study we evaluated the metabolic profile, including serum ghrelin, leptin and adiponectin levels, in normal weight,
overweight and obese school children and we analyzed the potential changes in anthropometric and metabolic
risk factors after a 1-year lifestyle intervention program.
Methods: Parameters were assessed at baseline and at 1 year. Three groups (G) were defined according the
International Obesity Task Force reference values, G1: normal weight / G2: overweight / G3: obese. The lifestyle
intervention included dietary counseling, regular physical activity and family support.
Results: A total of 120 children (G1: n = 44, G2: n = 39, G3: n = 37), aged 11– 15 years and 59 % girls were enrolled.
Obese children showed significant lower HDL-C, adiponectin and ghrelin concentrations, higher triglycerides,
fasting blood glucose, insulin and leptin levels and also higher frequencies of abdominal obesity (G1: 2.3 %, G2:
28.2 %, G3: 73 %) and insulin resistance (GI: 39 %, G2: 72 %, G3: 89 %) than the other groups. In the overall sample,
the linear regressions exploring the associations of ghrelin, adiponectin and leptin with age, gender, BMI z-score,
HOMA-IR and tanner stage as independent variables showed strong associations of leptin levels with weight status
and insulin resistance at baseline. The models accounted for 58 % of variability in leptin levels compared with 26
and 15 % for adiponectin and ghrelin levels respectively.
In 83 children who completed the program, significant decreases in BMI z-score in overweight and obese children
were noted. Leptin levels decreased significantly only in the obese group whereas adiponectin concentrations
increased significantly in the three groups,
In obese children, a significant correlation was found between changes in BMI Z-score, and changes in leptin levels
(r = 0.39; P = 0.049) but not with changes in adiponectin levels.
Conclusions: Abdominal obesity and insulin resistance were highly prevalent in obese children highlighting their
risk of metabolic complications in adulthood. A 1-year long lifestyle intervention was associated with improvement
in BMI z-score and metabolic parameters.
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Background
Obesity is a growing health problem worldwide. In the
French Caribbean island of Guadeloupe, overweight and
obesity were recently estimated at 23 and 9 % respectively
among children aged 5–14 years [1]. In this island, a high
prevalence of diabetes (8 %) is also observed in the adult
population. The causes of obesity are multifactorial but
the main factor contributing to excessive weight gain in
children should be the imbalance between energy intake
and energy expenditure. The presence of obesity in child-
hood is associated with adverse effects on health including
metabolic complications in which numerous cytokines
and hormones are involved.
Among these cytokines, leptin and adiponectin, pro-
duced by adipose tissue, appear to play a role in glucose
and lipid metabolism and energy homeostasis [2].
Ghrelin an orexigene hormone that also plays a role in
energy metabolism by stimulating food intake and favor-
ing weight and fat gain, has been recognized as an im-
portant regulator of glycemia and insulinemia [3].
Childhood obesity is a predictor of adult obesity and
metabolic syndrome that are risk factors of morbidity
and mortality [4–7] and, studies of long-term health
consequences in adolescent males found that even mod-
erate overweight is associated with excess mortality in
adulthood [8].
Because lifestyle habits settle during childhood, it was
recommended to precociously stop or prevent weight
gain in overweight children notably by promoting life-
style changes. These changes might also help to reduce
obesity associated comorbidities.
Studies have analyzed the relationship between these
hormones or cytokines and metabolic risk factors ac-
cording to children's weight status [7, 9, 10]. But few
studies have reported the concomitant variations of
these factors after a lifestyle intervention [7, 11–13]. In
addition, no data are available for these cytokines and
metabolic risk markers in our children population.
Therefore, in the present study: 1) we evaluated the
metabolic profile, including serum ghrelin, leptin and
adiponectin levels, in schoolchildren classified as nor-
mal weight, overweight and obese and 2) we analyzed
the potential changes in anthropometric and metabolic




We performed a cross-sectional analysis of basal data
and a prospective study to evaluate after 1 year, the
changes in children profiles in Guadeloupe Island (FWI).
Study population
In 2013, children from a middle school were invited to
participate in the study. They were eligible if they were
i) aged between 11 and 15 years, ii) affiliated to a social
security scheme and iii) in good health conditions. Ex-
clusion criteria included seizure disorders, diabetes, car-
diovascular disease or pregnancy.
The study was approved by the Ethic Committee
(South West - Overseas III, Bordeaux, France) in October
2012 and the French National Agency for Medecine and
Health Products Safety Security (ANSM). Written in-
formed consent, to participate in this study, was obtained
from all children and parents.
Study protocol
At baseline, anthropometric and biochemical measure-
ments were carried out in all children and, children and
accompanying parents fulfilled questionnaires on lifestyle.
We conducted a 1-year lifestyle intervention program
including 1) a nutritional information session presented,
at the start of the study, by a nutritionist explaining
healthy eating and nutrient needs to children and par-
ents 2) Information on health risks for diseases related
to lack of exercise and overweight 3) Encouragement for
reduction of sedentary behaviors 4) Advices to achieve
five hours per week of school physical education and/or
physical activity outside of school and 5) Participation of
parents.
The school usually provided three hours per week of
physical education, supervised by physical education
teachers.
Phone calls were made to maintain adherence to the
program and, in voluntary children, anthropometric clinical
Fig. 1 Changes in HOMA-IR index, leptin and adiponectin levels in normal-weight, overweight and obese children after a 1 year of lifestyle intervention.
HOMA-IR normal weight: P = 0.065, overweight: P = 0.079, obese: P = 0.011. Leptin levels normal weight: P = 0.234, overweight: P = 0.857, obese:
P = 0.008. Adiponectin levels normal weight: P = 0.001, overweight: P = 0.002, obese: P < 0.001
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and biological parameters (except ghrelin concentrations)
were evaluated after the 1-year lifestyle intervention.
Data collection
Clinical and biological examinations were performed at
the referring Health Centre of Guadeloupe (AGREXAM).
Participants were interviewed by a research Engineer and
physicians using standard questionnaires that provided in-
formation on age, sex, anthropometric measurements,
lifestyle and use of treatments.
Anthropometric measurements were performed by
trained nurses. Height in centimeters (cm) and weight in
kilograms (kg) were measured with participants standing
without shoes and lightly clothed. The body mass index
(BMI) was calculated as weight/height2 (kg/m2). The
standard deviation score of body mass index (BMI
Z-score) was used to provide a standard indicator of
relative adiposity [14] and was calculated as [(measured
value – average value in the reference population)/standard
deviation in the reference population] using a “Pediatric
z-Score Calculator”. Waist circumference (WC) in cen-
timeters (cm) was measured in a standing position at
the navel level at minimal respiration and the waist-to-
height ratio (WHtR) was calculated.
Systolic and diastolic blood pressure (SBP and DBP, re-
spectively) were assessed using automated monitors after
resting for at least 5 min. The retained values were the
average of two readings (left and right arms).
Pubertal stage was assessed according to Tanner [15].




Blood samples were collected by venipuncture after an
overnight fast. The biochemical analyses were performed
in a single laboratory using the same methods.
Blood glucose level (mmol/L) was assessed using the
glucose oxidase method. Serum lipid levels (mmol/L)
were measured enzymatically.
Serum insulin levels (μIU/mL) were measured using
the COBAS electro chemiluminescence immune assay
test (Roche Diagnostics, Basel, Switzerland). The
homeostasis model assessment to determined insulin
resistance (HOMA-IR) was calculated using the fol-
lowing formula: [fasting insulin (μIU/mL) x fasting
glucose (mmol/L)/22.5] [16].
Plasma samples were frozen at −80 °C until measure-
ments of ghrelin, leptin and adiponectin and assayed in
duplicate. Total ghrelin (ng/L) was measured with RIA
kit Merck-Millipore® (EZGRT-89 K), leptin ng/mL and
total adiponectin (μg/mL) were measured with ELISA
kits Biovendor® (RD191001100) and Alpco® (47-
ADPHUE-01) respectively. These measurements were
made concomitantly for the samples collected at base-
line and at one year (end of the study).
Definition of factors
Weight status The children were classified according to
the definition of overweight and obesity by the Inter-
national Obesity Task Force (IOTF), that provide age
and sex specific cut off points in childhood (from 2–18
years), predicting the accepted adult cut off points of a
BMI of 25 and 30 kg/m2 (for overweight and obesity
respectively) [17]. The three categories were defined as fol-
lows: normal weight with BMI < IOTF-25 kg/m2, over-
weight with BMI ≥ IOTF-25 kg/m2 and BMI < IOTF-
30 kg/m2 and obesity.with BMI ≥ IOTF-30 kg/m2.
Abdominal obesity in children was defined as WHtR
greater or equal to 0.5 [18].
Blood lipid abnormalities was defined as HDL-
cholesterol <1.03 or TG ≥ 1.7 [18].
Insulin resistance was defined by a HOMA-IR > 3.16 [19].
Statistical analysis
Data are presented as numbers (percentages) for cat-
egorical variables and as means ± standard deviations
(SD) for continuous variables. The chi-squared test and
ANCOVA with adjustment for age, sex were used to test
percentage and mean differences between the three
groups. Non parametric tests were used for comparison
between data at baseline and 1-year.
The Pearson correlation test was used to study the re-
lationships between serum ghrelin, leptin, adiponectin
concentrations and the other continuous variables.
We also used the multivariate linear regressions in the
overall study population to evaluate the associations of
serum ghrelin, leptin and adiponectin as dependent vari-
ables and age, gender, weight status, Tanner stage and
HOMA-IR as independent variables.
The IBM SPSS Statistics software version 21 was used for
data analyses. All tests were two-sided and a P value < 0.05
was considered significant.
Results
Analysis of parameters at baseline
Overall 120 children of both sexes were enrolled in the
study.
The accompanying parents were 80 % women and 20 %
men. Forty four (37 %) of them were overweight/obese
(BMI > 25 kg/m2) and 29 % were obese (BMI ≥ 30 kg/m2).
Family history of diabetes was noted in 50 % of accom-
panying parents and 7 % had personal history of diabetes.
The children were categorized into three groups:
group 1 (G1: normal weight; n = 44), group 2 (G2: over-
weight; n = 39) and group 3 (G3: obeses; n = 37). The
characteristics of the study population according to
weight status at baseline are presented in Table 1.
Rambhojan et al. Nutrition & Metabolism  (2015) 12:43 Page 3 of 10
The mean age of the study population was 12.4 ±
1.1 years and 59 % were girls. Tanner stages were distrib-
uted as follows: stage 2: 7.5 %, stage 3: 58.3 %, stage 4:
30 % and stage 5: 4.2 %.
Overall, 92.5 % of the children had a tanner stage ≥ 3
(pubertal/post pubertal development) with no significant
difference between the three groups (P = 0.82, Table 1).
The frequency of children eating at school canteen was
higher in normal weight (53 %) than in overweight
(28 %) and obese (30 %) children; (P = 0.027), (data not
shown).
In accordance with the design of the study, all the an-
thropometric parameters (BMI, BMI z-score, WC and
WC/height) were significantly different between the three
groups (P < 0.001 for all parameters). Obese children had
higher SBP (P = 0.015), triglycerides (P = 0.007), fasting
blood glucose (P = 0.019), insulin (P < 0.001) and lep-
tin levels (P < 0.001), whereas they had lower HDL-C
(P < 0.001), ghrelin (P = 0.001) and adiponectin levels
(P < 0.001) than the other groups. Abdominal obesity
and insulin resistance were also more frequently found in
the obese group (P < 0.001 for both).
Leptin levels were higher in girls than in boys in the
overall study sample (27 vs 16 ng/mL; P = 0.004) whereas
no significant gender differences were found for adipo-
nectin (P = 0.164) and ghrelin levels (P =0.110).
The correlations between leptin, ghrelin, adiponectin
levels and the other continuous variables: anthropomet-
ric parameters, blood lipids and insulin levels, among
boys and among girls respectively are presented in
Table 2a and b. Leptin, ghrelin, adiponectin levels were
significantly correlated with the three anthropometric
parameters (BMI z score, WC, WHt) in both genders
except for ghrelin in girls. Concerning FBG and blood
lipid parameters, in boys, significant correlations were
found except for ghrelin with TG levels, for leptin with
FBG and LDL-C and for adiponectin with FBG, LDL-C
and TG levels. In girls, no significant correlation was
Table 1 Characteristics of school-children 11 to 15 years according to weight status at baseline
Parameters Overall Normal-weight Overweight Obese P
n =120 n =44 n =39 n =37
Sex (girls) 59.2 % 52.3 % 69.3 % 56.8 % 0.270
Age (Years) 12.4 ± 1.1 12.2 ± 1.0 12.5 ± 1.2 12.7 ± 1.1 0.130
BMI (Kg/m2) 24.1 ± 6.1 18.4 ± 2.3*** 24.2 ± 1.6¥¥¥ 30.1 ± 4.9§§§ <0.001
BMI z-score 1.08 ± 1.18 −0.17 ± 1.04*** 1.47 ± 0.23¥¥¥ 2.15 ± 0.26§§§ <0.001
WC (cm) 73.9 ± 12.9 62.9 ± 7.1*** 75.1 ± 6.5¥¥¥ 86.6 ± 10.3§§§ <0.001
WHtR 0.46 ± 0.08 0.39 ± 0.04*** 0.47 ± 0.04¥¥¥ 0.53 ± 0.06§§§ <0.001
Abdominal obesity (%) 32.5 % 2.3 %*** 28.2 %¥¥ 73.0 %§§§ <0.001
Tanner stage≥ 3 (pubertal/post pubertal) 92.5 % 90.9 % 92.3 % 94.6 % 0.82
SBP (mmHg) 113 ± 10 110 ± 9** 113 ± 8 116 ± 12 0.015
DBP (mmHg) 68 ± 8 66 ± 6 69 ± 9 70 ± 7 0.126
HDL-Cholesterol (mmol/L) 1.32 ± 0.35 1.52 ± 0.36*** 1.22 ± 0.28¥¥¥ 1.18 ± 0.28§§§ <0.001
HDL-Cholesterol < 1.03 mmol/L(%) 21.7 % 11.4 % 28.2 %¥ 27.0 % 0.261
LDL-Cholesterol (mmol/L) 2.57 ± 0.67 2.55 ± 0.72 2.59 ± 0.62 2.57 ± 0.69 0.970
Triglycerides(mmol/L) 0.78 ± 0.44 0.66 ± 0.34*** 0.74 ± 0.35 0.95 ± 0.57 0.007
Triglycerides ≥ 1.7 mmol/L (%) 4.2 % 0 %* 5.1 % 8.1 % 0.287
Fasting blood glucose (mmol/L) 4.8 ± 0.4 4.7 ± 0.4 4.8 ± 0.4 4.9 ± 0.4 0.019
Insulin (μIU/mL) 21.3 ± 12.9 14.6 ± 4.6*** 21.7 ± 13.9¥ 28.8 ± 14.3§ <0.001
HOMA-IR 4.6 ± 3.0 3.5 ± 1.1*** 4.7 ± 3.0¥ 6.5 ± 3.5§ <0.001
HOMA-IR > 3.16 (%) 65.0 % 38.6 %*** 71.8 %¥¥ 89.2 % <0.001
Ghrelin (ng/L) 1379 ± 488 1541 ± 514* 1355 ± 440 1221 ± 457 0.012
Leptin ng/mL 22.9 ± 20.4 8.5 ± 6.1*** 23.6 ± 12.6¥¥¥ 39.6 ± 22.9§§§ <0.001
Adiponectin μg/mL 5.4 ± 2.6 6.8 ± 2.8*** 4.9 ± 2.2¥¥ 4.1 ± 1.8 <0.001
Data in this table are mean ± SD and column percentage
BMI body mass index, WC waist circumference, WHtR wait-to-height ratio, SBP systolic blood pressure, DBP diastolic blood pressure, HDL-C high density lipoprotein
cholesterol, LDL-C low density lipoprotein cholesterol, TG triglycerides, HOMA-IR homeostasis model assessment-insulin resistance
P: P value for global comparison between the three groups
Comparison for normal-weight vs obese children * P < 0.05, ** P < 0.01, *** P < 0.001
Comparison for normal-weight vs overweight children ¥P < 0.05, ¥¥P < 0.01, ¥¥¥P < 0.001
Comparison for overweight vs obese children: §P < 0.05, §§P < 0.01, §§§P < 0.001
All p-values are in italic and significant p-value are in bolditalic
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found for ghrelin with the 4 parameters, for leptin with
LDL-C and for adiponectin with LDL-C and TG.
High significant correlations were also noted between
ghrelin, leptin and adiponectin levels with insulin levels and
HOMA-IR in both genders except for ghrelin levels in girls.
All anthropometric parameters were positively corre-
lated with insulin and HOMA-IR in both genders (data
not shown).
In considering the weight status of accompanying par-
ents, insulin resistance (HOMA IR > 3.16) was noted in
61 % of children from parents with normal weight and
in 70 % of children from overweight or obese parents
(data not shown).
Table 3 presents the results of the multivariate linear
regression analyses exploring the associations of ghrelin,
adiponectin and leptin with age, gender, weight status,
HOMA-IR and tanner stage as independent variables, at
baseline.
In model 1, for ghrelin levels, no significant associ-
ation was noted with the five variables but association
with HOMA-IR was nearly significant (P = 0.070). The
model accounted for 15 % (r2 = 0.15) of the variability in
ghrelin levels.
In model 2, for adiponectin levels, significant negative
associations were noted with overweight (P = 0.002),
obesity (P = 0.001) and HOMA-IR (P = 0.010) and the
model accounted for 26 % (r2 = 0.26) of the variability in
adiponectin levels.
In model 3, for leptin levels, significant positive asso-
ciations were noted with gender (P = 0.011), overweight
(P < 0.001), obesity (P < 0.001) and HOMA-IR (P = 0.002).
The average increase in leptin levels was 7.9 ng/dL for
gender (girls), 13.9 ng/dL for overweight, 26.4 ng/dL for
obesity and 1.50 ng/dL for each unit of HOMA-IR. This
multivariate model accounted for 58 % (r2 = 0.58) of the
variability in leptin levels.
Table 2 Correlations between Ghrelin, Adiponectin and Leptin and anthropometric and metabolic parameters among school-children
by gender 11 to 15 years at baseline
Parameters 2a: Boys 2b: Girls
Ghrelin (ng/L) Leptin(ng/mL) Adiponectin (μg/mL) Ghrelin (ng/L) Leptin(ng/mL) Adiponectin (μg/mL)
r P r P r P r P r P r P
BMI z-score −0.59 <0.001 0.70 <0.001 −0.40 0.005 −0.08 0.523 0.66 <0.001 −0.40 0.001
WC (cm) −0.64 <0.001 0.78 <0.001 −0.46 0.001 −0.12 0.313 0.79 <0.001 −0.46 <0.001
WHtR −0.51 <0.001 0.85 <0.001 −0.36 0.013 −0.10 0.399 0.73 <0.001 −0.50 <0.001
FBG (mmol/L) −0.37 0.001 0.25 0.087 −0.10 0.483 0.07 0.587 0.36 0.003 −0.32 0.006
HDL-C (mmol/L) 0.41 0.005 −0.36 0.013 0.57 <0.001 0.16 0.190 −0.39 0.001 0.46 <0.001
LDL-C (mmol/L) 0.36 0.014 0.28 0.058 0.11 0.485 0.17 0.149 −0.05 0.707 −0.02 0.881
TG (mmol/L) −0.10 0.492 0.53 <0.001 −0.18 0.238 0.21 0.076 0.25 0.038 −0.07 0.585
Insulin (μU/mL) −0.52 <0.001 0.55 <0.001 −0.44 0.002 −0.13 0.267 0.47 <0.001 −0.35 0.003
HOMA-IR index −0.53 <0.001 0.57 <0.001 −0.44 0.002 −0.11 0.357 0.50 <0.001 −0.36 0.003
BMI body mass index, WC waist circumference, WHtR wait-to-height ratio, FBG Fasting blood glucose, HDL-C high density lipoprotein cholesterol, LDL-C low density
lipoprotein cholesterol, TG triglycerides, HOMA-IR homeostasis model assessment-insulin resistance
All p-values are in italic and significant p-value are in bolditalic
Table 3 Multivariate linear regression for Ghrelin, Adiponectin and Leptin levels in 120 schoolchildren 11 to 15 years, at baseline
Model 1 Ghrelin (ng/L) Model 2 – Adiponectin (μg/mL) Model 3 Leptin (ng/mL)
r2 = 0.15 r2 = 0.26 r2 = 0.58
Adjusted r2 = 0.11 Adjusted r2 = 0.22 Adjusted r2 = 0.56
Variables nSRC (SE) P nSRC (SE) P nSRC (SE) P
Age (Years) −113 (88) 0.205 0.44 (0.44) 0.318 3.18 (2.61) 0.226
Gender (girls) −71 (102) 0.488 0.68 (0.51) 0.187 7.87 (3.02) 0.010
Weight Status
Overweight −81 (109) 0.455 −1.67 (0.53) 0.002 13.88 (3.15) <0.001
Obese −164 (119) 0.171 −2.10 (0.59) 0.001 26.36 (3.49) <0.001
Tanner stage 2 to 5 52 (135) 0.689 −0.45 (0.68) 0.508 −0.73 (4.01) 0.856
HOMA-IR −29 (16) 0.071 −0.21 (0.08) 0.010 1.50 (0.47) 0.002
nSRC non standardized regression coefficient, SE standard error, HOMA-IR homeostasis model assessment forinsulin resistance
All p-values are in italic and significant p-value are in bolditalic
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No significant average change in ghrelin, leptin and
adiponectin levels was noted in relation with tanner
stage.
Table 4 presents changes in clinical and metabolic pa-
rameters at one year of follow-up. Of the 120 children
who participated to the study at baseline, 83 have ac-
cepted to undergo evaluation for clinical and biological
parameters after one year (28 in normal weight, 28 in
overweight, and 27 in obese children).
Mean BMI z-score significantly decreased in over-
weight (1.47 to 1.33; P = 0.021) and obese children (2.18
to 2.08; P = 0.008) whereas, no significant change was noted
in the normal weight group (−0.10 to −0.16; P = 0.446)
(Table 4).
Concerning the metabolic parameters, significant de-
creases were observed in normal weight children for
LDL-C (P = 0.018) and insulin levels (P =0.048). The
HDL-C levels decreased in this group (P <0.001) but
remained higher than in the other groups. Fasting blood
glucose (P = 0.047), LDL-C (P = 0.015) and insulin levels
(P = 0.019) improved in overweight children. In obese
children, significant improvements were also observed in
FBG (P = 0.002), insulin levels (P = 0.019) and HOMA-IR
(P = 0.011). Significant rises in adiponectin levels were
observed in normal weight overweight and obese chil-
dren (P = 0.001, P = 0.002, P < 0.001 respectively). Leptin
levels remained unchanged at 1 year of follow-up in nor-
mal weight and overweight children but decreased sig-
nificantly in obese children (P = 0.008). Table 4 and fig. 1
present changes in clinical and metabolic parameters at
one year of follow-up.
Combining the results of the three groups, a nearly
significant correlation was found between changes in BMI
z-score, and changes in leptin concentrations (r = 0.20;
P = 0.060). This positive correlation was significant in
the obese group (r = 0.39; P = 0.049). Conversely no sig-
nificant correlation was found between changes in BMI
z-score, and both changes in HOMA-IR and adiponec-
tin levels (data not shown).
We evaluated the frequencies of children undergoing
concomitant changes in the three metabolic parameters
at 1 year (decrease HOMA IR and leptin levels and in-
crease adiponectin levels) and we found a frequency of
27 % in children from parents with normal weight and
of 37 % in children from overweight or obese parents.
Discussion
The current study is the first to evaluate the metabolic
profile in overweight and obese Guadeloupean children.
Obesity was associated with an adverse metabolic profile
including, high frequencies of abdominal obesity (73 %)
and of insulin resistance (89 %) highlighting the risk for
development of type 2 diabetes and future cardiovascu-
lar complications in adulthood [4, 20]. These obese chil-
dren also exhibited, at baseline, the highest values for
triglycerides and leptin levels and the lowest values for
HDL-cholesterol, ghrelin and adiponectin levels. In
addition, leptin levels appeared to have a stronger rela-
tionship with weight status and HOMA-IR than ghrelin
and adiponectin at baseline which is in favor of a role of
leptin in body weight regulation [21]. Our 1-year collab-
orative lifestyle intervention, led to improvements in
BMI z-score and in most of the metabolic parameters
particularly in the obese children. The results, after the
intervention, also showed that changes in BMI z-score
correlated with changes in leptin levels. Leptin levels de-
creased significantly only in the obese group whereas
adiponectin concentrations increased in normal weight,
overweight and obese children.
Anthropometric parameters
All the anthropometric parameters (WC, WHtR and
BMI Z-score) were significantly correlated with ghrelin,
leptin and adiponectin except in girls in whom no cor-
relation with ghrelin was observed. Abdominal obesity,
defined in children as WHtR greater than 0.5 [18], has
Table 4 Clinical and biological parameters in 83 children at baseline and after 1 year of a lifestyle intervention program
Parameters Normal-weight (n = 28) Overweight (n = 28) Obese (n = 27)
Baseline T1-year P Baseline T1-year P Baseline T1-year P
BMI z-score −0.10 ± 1.03 −0.16 ± 0.85 0.446 1.47 ± 0.24 1.33 ± 0.44 0.021 2.18 ± 0.27 2.08 ± 0.40 0.008
FBG (mmol/L) 4.67 ± 0.38 4.63 ± 0.34 0.690 4.82 ± 0.42 4.69 ± 0.42 0.047 4.95 ± 0.40 4.69 ± 0.35 0.002
HDL-C (mmol/L) 1.59 ± 0.36 1.45 ± 0.31 <0.001 1.21 ± 0.28 1.18 ± 0.21 0.425 1.19 ± 0.29 1.14 ± 0.28 0.248
LDL-C (mmol/L) 2.61 ± 0.75 2.37 ± 0.66 0.018 2.68 ± 0.59 2.48 ± 0.48 0.015 2.46 ± 0.59 2.43 ± 0.47 0.410
TG (mmol/L) 0.55 ± 0.26 0.56 ± 0.24 0.945 0.78 ± 0.40 0.73 ± 0.39 0.682 0.86 ± 0.32 0.80 ± 0.36 0.254
Insulin (μU/mL) 13.4 ± 3.6 11.8 ± 6.1 0.048 19.9 ± 12.5 15.8 ± 7.0 0.019 28.4 ± 13.7 26.2 ± 17.7 0.019
HOMA-IR index 2.80 ± 0.86 2.48 ± 1.37 0.065 4.18 ± 3.04 3.31 ± 1.56 0.079 6.32 ± 3.19 5.53 ± 3.95 0.011
Leptin (ng/mL) 6.0 ± 5.19 6.78 ± 1.9 0.234 25.0 ± 13.0 25.5 ± 18.1 0.857 37.7 ± 22.5 33.4 ± 24.2 0.008
Adiponectin (μg/mL) 6.43 ± 2.51 7.98 ± 3.56 0.001 5.17 ± 2.39 6.71 ± 2.77 0.002 3.96 ± 1.84 5.0 ± 2.41 <0.001
FBG fasting blood glucose, BMI body mass index, WC waist circumference, HOMA-IR homeostasis model assessment for insulin resistance
All p-values are in italic and significant p-value are in bolditalic
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been associated in adulthood with cardio vascular com-
plications [18] and was found in 2.3 % of normal weight,
28.2 % of overweight and 73 % of our obese children.
In a recent review, the authors recommended to pay
more attention to abdominal obesity in children and ad-
olescents because central body fat deposition increases
the risk of cardio-metabolic risk factors, whatever the
definition used for abdominal obesity and whatever the
methods used for anthropometric measurements, [22].
Metabolic profile, ghrelin and cytokines
The lowest HDL-C concentrations, the highest triglycer-
ides and FBG concentrations and the highest values for
HOMA-IR index were observed in the obese children. It
is well known that obesity is associated with comorbidi-
ties such as dyslipidemia, hypertension, insulin resist-
ance [20, 23] and with early indication of atherosclerosis
[24, 25]. We also observed high frequencies of insulin
resistance (defined as HOMA-IR greater than 3.16) in
obese (89 %), overweight (72 %) and normal weight chil-
dren (39 %). Insulin sensitivity index was previously re-
ported lower in black compared with white adolescents
suggesting a more diabetic profile in the first group [26].
In our general population in which most people are of
African ancestry and diabetes is highly prevalent (8 %),
the results observed in children and adolescents high-
light their high risk of metabolic complications. This risk
is probably increased due to children family history
showing 50 % of overweight and 7 % of diabetes in ac-
companying parents.
Despite ghrelin levels were not significantly associated
with HOMA-IR in the linear regression (Table 3), the
hormone has been recognized as an important regulator
of energy metabolism and serves as a physiological regu-
lator of insulinemia and glycemia [3].
Adipose tissue is considered as an endocrine organ
producing several proteins (including leptin and adipo-
nectin) with important biological activity and, the adipo-
cyte plays a central role in the balance, or imbalance, of
metabolic homeostasis [27]. Adiponectin levels were the
lowest and leptin levels the highest in the obese group.
Numerous studies described significant negative correla-
tions between adiponectin and the parameters of obesity.
Low adiponectin concentrations which has been previ-
ously associated with coronary artery disease in the adult
population of Guadeloupe [28] correlated with high
plasma insulin levels and adverse blood lipid profile in
the present study in children. Lower adiponectin levels
in obesity were also associated with chronic inflamma-
tion, endothelial dysfunction, and insulin resistance [29,
30]. The three multivariate linear regression models for
ghrelin, adiponectin and leptin levels, as dependent vari-
ables (Table 3) and age, gender, weight status, tanner stage
and HOMA-IR as independent variables, highlighted the
strong associations of leptin and adiponectin levels with
body weight and insulin resistance at baseline. The model
accounted for 58 % of variability in leptin levels compared
with 26 and 15 % of variability in adiponectin and in
ghrelin levels respectively. Leptin levels increased signifi-
cantly by 1.50 ng/ml for each unit of HOMA-IR. These
strong relationships were also reported in a study on 321
children (109 normal, 212 obese) aged 6–12 years, analys-
ing leptin, ghrelin, adiponectin levels [10]. In this study,
leptin was found as the most sensitive adipokine marker
for predicting the accumulation of cardiovascular risk fac-
tors and the presence of metabolic syndrome [10]. The
gender difference for leptin levels, previously reported in
children and adults [7, 21, 31–33], was also found in our
study with girls exhibiting higher values than boys. This
difference might reflect the higher ratio of subcutaneous
to visceral fat in women than in men since serum leptin is
strongly related to subcutaneous fat mass [21]. But, other
factors besides adiposity, such as sex steroids, might play a
role in this gender difference [21].
Leptin administration has been demonstrated to re-
duce obesity in leptin-deficient ob/ob mice [34] and, to
decrease food intake, body weight, increase energy ex-
penditure and improve metabolic status in leptin defi-
cient subjects [35, 36]. But, in most individuals, serum
leptin levels are positively correlated with BMI and with
indexes of obesity. Thus, the concept of leptin resistance
has emerged to explain the paradoxical elevated leptin
levels in obesity. Several mechanisms have been sug-
gested to explain this leptin resistance, notably the im-
paired transport of leptin across blood brain barrier [37],
or decrease of hypothalamic leptin receptor expression
[38] as well as attenuation of leptin signaling by protein
tyrosine phosphatases [39].
The mechanism by which increased body fat cause in-
creased metabolic comorbidities is not really known. It
was suggested that excess adipose tissue contribute to a
state of chronic inflammation which promotes develop-
ment of insulin resistance as well as other metabolic com-
plications [40]. Leptin and adiponectin show opposite
effects on inflammation and insulin resistance. While high
leptin levels increase the expression of pro-inflammatory
and pro-angiogenic factors [41] adiponectin, improves
peripheral insulin sensitivity, and induces the production
of anti-inflammatory cytokines [42].
Changes in anthropometric and metabolic parameters
after 1 year follow-up
In this study population without significant differences
between groups in age, sex and Tanner stage distributions,
we observed after the 1-year lifestyle intervention, a redu-
cing in BMI z-score in overweight and obese children and
improvements in most of the metabolic parameters with
greater benefits in the obese group. This group showed
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significant improvements in fasting insulin levels,
HOMA-IR, leptin and adiponectin levels. These results
are interesting since increase of insulin levels, HOMA-
IR and leptin levels would be expected after one year
with increasing age or puberty. In fact, in EarlyBird, a
prospective cohort study of healthy children, insulin
resistance started to rise in mid-childhood, and HOMA-
IR rose, almost linearly, from age of 8 [43]. Ballabriga A
et al. reported that both prepubertal boys and girls showed
a progressive increase of leptin levels during the years
prior to the onset of puberty and until Tanner's stage
11 [44].
Serum leptin is believed to play a role in obesity but,
although leptin levels were strongly associated with
HOMA-IR and weight status at baseline, in the present
study, significant decrease in leptin levels were noted only
in obese children at one year follow-up. In other studies,
after lifestyle intervention or after exercise training pro-
gram, leptin levels decreased [45] or remained unchanged
[7, 13, 46]. In addition, leptin levels increased in children
without weight loss in one of these studies [13].
At one year of follow-up, adiponectin levels increased
significantly in the three groups although normal weight
children showed no significant reduction of BMI z-
score. Cambuli et al. evaluated adipokines levels but also
fat-free mass and fat mass, before and after 1 year of life-
style intervention in 104 overweight and obese children
[13]. In this study, adiponectin in particular increased
from baseline at the end of the study. In addition, the
authors found that changes in adiponectin were signifi-
cantly and independently associated with changes in per-
cent fat mass and that, even those children who did not
lose weight obtained a significant reduction in percent
fat mass [13]. It was previously reported that high adipo-
nectin concentrations predicted lower prevalence of type
2 diabetes in obese Mexican children [47] and that low
adiponectin concentrations were associated with in-
creased risk of type 2 diabetes in adults [48, 49]. But,
high leptin levels were not associated with risk of inci-
dent type 2 diabetes in an Aboriginal Canadian popula-
tion [48]. In our population having a high prevalence of
type 2 diabetes, adiponectin could be a tool for monitor-
ing overweight or obese children having marked insulin-
resistance.
Implications in prevention of overweight in children
The efficiency of lifestyle intervention for childhood
obesity has been previously reported with changes in
body weight but also changes in metabolic parameters.
Moreover, obesity treatment programs are more effective
in reducing overweight in children if parents are in-
volved. The positive effect of eating in school canteen
should be highlighted. Our children with normal weight
ate more frequently in school canteen than the other
groups. In fact, it is a beneficial factor since the menus
follow the recommendations designed to lower fat and
sugar and increase vegetables and fruit in meals. In
addition, the children can take advantage of the infra-
structure for physical activity and sport activities pro-
posed by the school.
Limitation and strengths of the study
The potential limitations of our study include i) the
small sample size even if other lifestyle intervention
studies were conducted on small sample sizes [7, 12, 13]
and ii) the absence of controls groups (without lifestyle
intervention) that did not let us draw any causality link
between the lifestyle intervention and the improvement
of the parameters studied.
Nevertheless, the present study has a number of
strengths. i) the children were healthy, comparable be-
tween groups for age, sex and Tanner stage distribu-
tions and presented no associated diseases that could
influence the metabolic profile, ii) the use of traditional
markers for metabolic disease (ie, lipid profile, insulin
levels, HOMA-IR) and the measurement for the first
time of adiponectin, leptin and ghrelin concentrations
in a sample of Guadeloupean children and iii) the pro-
viding of data on changes in metabolic parameters at
the end of the lifestyle intervention.
Conclusion
Abdominal obesity and insulin resistance, that could
precede other metabolic complications, were frequent in
obese children highlighting their high risk of obesity and
type 2 diabetes in adulthood. The 1-year collaborative
lifestyle intervention, involving children parents and
teachers seems rather beneficial, notably in obese chil-
dren, with improvements in body composition, insulin,
leptin and adiponectin levels. This improvement is
probably the result of different factors including the
fight against sedentary lifestyles and changes in eating
habits in the families.
These results might be used to encourage parents to
participate in prevention programs against overweight.
In addition, sensitization of families (children and accom-
panying) on health risks related to sedentary behaviors
must be continuous.
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